Ajai Chari
MD
Professor of Medicine
👥Biography 个人简介
Ajai Chari is a leading myeloma immunotherapy researcher who has been central to the development of talquetamab, a GPRC5D-targeting bispecific antibody. His clinical research has characterized the unique toxicity profile of GPRC5D-directed therapy including dysgeusia and skin changes. He has contributed to establishing management guidelines for bispecific antibody adverse events.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Ajai Chari 的研究动态
Follow Ajai Chari's research updates
留下邮箱，当我们发布与 Ajai Chari（University of California San Francisco）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment